Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128590) titled 'Observational Study Following Fixed-Dose Treatment with Buagafuran Capsule in Generalized Anxiety Disorder' on July 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Anding Hospital Affiliated to Capital Medical University
Condition:
Generalized Anxiety Disorder
Intervention:
High-dose group:N/A
Placebo control group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-27
Target Sample Size: High-dose group:17;Placebo control group:16;Low-dose group:17;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn...